Regarding the April 19 news article “ Trump orders agencies to boost research of psychedelics ”: ...

Natural psychoactive compounds have gained traction as possible treatments for mental illnesses, brain injuries, dementia and ...

The Trump administration’s moves on marijuana and psychedelics signal the start of a new era in Republican drug policy. The ...

After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use.

The president will direct federal agencies to boost research into the drugs and support clinical trials, moves championed by ...

Psychedelic therapy shows promise, but what makes its effects last? The answer may lie not in the drug, but in what happens ...

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like ...

Last weekend, President Donald Trump signed an executive order aimed at accelerating the review of psychedelic therapies for ...

The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying ...

Psychedelic therapy shows promise, but what makes its effects last? The answer may lie not in the drug, but in what happens ...

The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially ...

A new executive order could make it easier for researchers studying how psychedelic drugs such as psilocybin, LSD and ...